Tricuspid stenosis pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
{{ | {{Tricuspid stenosis}} | ||
{{CMG}} | {{CMG}} | ||
==Pathophysiology== | ==Pathophysiology== | ||
| Line 13: | Line 11: | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category: Cardiology]] | {{Circulatory system pathology}} | ||
{{Congenital malformations and deformations of circulatory system}} | |||
[[Category: Valvular heart disease]] | |||
[[Category:Disease]] | |||
[[Category:Cardiology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 18:09, 24 June 2011
|
Tricuspid stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid stenosis pathophysiology On the Web |
|
American Roentgen Ray Society Images of Tricuspid stenosis pathophysiology |
|
Risk calculators and risk factors for Tricuspid stenosis pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Pathophysiology
The tricuspid valve leaflets become thickened and sclerotic as the chordae tendineae become shortened. As a result of increased diastolic pressure, right atrial enlargement may be present.